8-bromo cyclic adenosine monophosphate has been researched along with Leukemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bezombes, C; Demur, C; Filomenko, R; Hernandez, H; Jaffrézou, JP; Laurent, G; Maestre, N; Mas, VM; Plo, I; Quillet-Mary, A | 1 |
Cloyd, MW; Kawa, S; Smith, JS; Thompson, EB | 1 |
Cho-Chung, YS | 1 |
Barge, RM; Falkenburg, JH; Maassen, JA; Willemze, R | 1 |
Allen, PD; Jia, L; Kelsey, SM; MacEy, MG; Newland, AC; Yin, Y | 1 |
1 review(s) available for 8-bromo cyclic adenosine monophosphate and Leukemia
Article | Year |
---|---|
Antisense DNA toward type I protein kinase A produces sustained inhibition of tumor growth.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antineoplastic Agents; Cell Differentiation; Cell Division; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; DNA, Antisense; Epithelial Cells; Humans; Leukemia; Neoplasms, Experimental; Tumor Cells, Cultured | 1997 |
4 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Leukemia
Article | Year |
---|---|
Protein kinase Czeta mediated Raf-1/extracellular-regulated kinase activation by daunorubicin.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylcysteine; Androstadienes; Antibiotics, Antineoplastic; Antioxidants; Bridged-Ring Compounds; Cell Death; Daunorubicin; Diglycerides; Enzyme Activation; Flavonoids; Humans; Leukemia; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Norbornanes; Phosphatidylcholines; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-raf; Reactive Oxygen Species; Thiocarbamates; Thiones; Transfection; Tumor Cells, Cultured; Wortmannin | 2003 |
Interactions between human immunodeficiency virus infection and hormonal pathways: enhancement of calcium-induced but reduction of glucocorticoid-induced cell death.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Alprostadil; Apoptosis; Bucladesine; Calcimycin; Calcium; Cell Death; Dexamethasone; Glucocorticoids; HIV-1; Humans; Leukemia; Protein Kinase C; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
8-Bromo-cAMP induces a proliferative response in an IL-3 dependent leukemic cell line and activates Erk 1,2 via a Shc-independent pathway.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Enzyme Activation; Interleukin-3; Leukemia; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mitogens; Phosphorylation; Tumor Cells, Cultured | 1997 |
Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Humans; Isoquinolines; Leukemia; NF-kappa B; Sulfonamides; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |